1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Echocardiographic findings focused on the inferior vena cava partly aid the diagnosis of cardiac amyloidosis

      case-report
      , ,
      European Heart Journal
      Oxford University Press

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cardiac amyloidosis is typically suspected based on various echocardiographic signs termed ‘red flags.’ 1 In this case, we present clinical and pathological findings focused on the inferior vena cava (IVC) in a patient with cardiac amyloidosis. A 95-year-old female was admitted at our hospital for shortness of breath. Upon admission, echocardiography revealed unexplained left ventricular thickness (interventricular septum thickness 14 mm, posterior wall thickness 13 mm) and brightness that resembled a granular sparkling sign with preserved ejection fraction (left ventricular ejection fraction 53%, Panel A). Because of her advanced age, the patient denied invasive clinical examinations and subsequently died of heart failure after 5 days. Pathological examination conducted at her family’s request revealed amyloid deposition in the left ventricular wall through direct fast scarlet (DFS) staining (Panel B). Retrospectively, echocardiography detected high-contrast and hypertrophy of the IVC wall (IVC wall thickness 3.0 mm, Panel C) compared with the normal range. 2 Macroscopic findings also showed venous hypertrophy and sclerosis (Panel D). Light microscopy specifically revealed extracellular deposition of misfolded proteins in the IVC wall (Panel E). DFS staining revealed diffuse amyloid deposition in the IVC wall (Panel F). Although a previous pathological report clarified that amyloid deposition can occur in the whole body including the veins, 3,4 this is the first clinical report focused on cardiac amyloidosis in the IVC. IVC findings on echocardiography, such as those observed in this case, may provide useful additional information in the diagnosis of cardiac amyloidosis. No new data were generated or analysed in support of this research. Taiki Tojo (Conceptualization: Supporting; Data curation: Supporting; Investigation: Supporting; Project administration: Lead; Supervision: Supporting; Visualization: Equal; Writing – review & editing: Lead), Ichiro Maeda (Data curation: Lead; Formal analysis: Lead; Investigation: Equal; Supervision: Lead; Writing—review & editing: Equal), and Kazuhiro Fujiyoshi (Conceptualization: Lead; Data curation: Equal; Formal analysis: Equal; Investigation: Lead; Project administration: Equal; Visualization: Lead; Writing—original draft: Lead) All authors declare no conflict of interest for this contribution. Figure 1 (Panel A) Echocardiographic image depicting a four-chamber view of the heart. (Panel B) The image of DFS staining revealed that the deposits were DFS positive at the myocardium. (Panel C) Echocardiographic image of the IVC wall (arrowheads). (Panel D) Macroscopic image of the IVC. Panel E) the image of the IVC stained by hematoxylin and eosin. (Panel F) The image of DFS staining revealed that the deposits were DFS positive at the media of IVC. IVC, inferior vena cava, DFS, direct fast scarlet.

          Related collections

          Most cited references3

          • Record: found
          • Abstract: found
          • Article: not found

          Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

          Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions. Thanks to advances in imaging techniques and the possibility of achieving a non-invasive diagnosis, we now know that cardiac amyloidosis is a more frequent disease than traditionally considered. In this position paper the Working Group on Myocardial and Pericardial Disease proposes an invasive and non-invasive definition of cardiac amyloidosis, addresses clinical scenarios and situations to suspect the condition and proposes a diagnostic algorithm to aid diagnosis. Furthermore, we also review how to monitor and treat cardiac amyloidosis, in an attempt to bridge the gap between the latest advances in the field and clinical practice.
            • Record: found
            • Abstract: found
            • Article: not found

            Cardiac amyloidosis: pathology, nomenclature, and typing.

            Amyloidosis is an increasingly recognized cause of heart disease, caused by the deposition of misfolded protein within the heart. These proteins may deposit systemically and include the heart or deposit only within the heart muscle itself. In either case, cardiac symptoms may be the primary manifestation. The diagnosis is usually made by the pathologist identifying amyloid within a tissue sample. The diagnosis, however, does not end with such visual recognition of the presence of amyloid. Newer generation pharmacotherapeutic agents that are protein specific necessitate a closer evaluation to determine the type of protein being deposited and accurately conveying this to the treating clinician. Herein, the gross and histopathologic features of cardiac amyloidosis are reviewed along with a review of amyloid typing strategies (both direct and indirect) that may be employed in the diagnostic workup as well as the nomenclature standards for reporting.
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The aging venous system: from varicosities to vascular cognitive impairment

              Aging-induced pathological alterations of the circulatory system play a critical role in morbidity and mortality of older adults. While the importance of cellular and molecular mechanisms of arterial aging for increased cardiovascular risk in older adults is increasingly appreciated, aging processes of veins are much less studied and understood than those of arteries. In this review, age-related cellular and morphological alterations in the venous system are presented. Similarities and dissimilarities between arterial and venous aging are highlighted, and shared molecular mechanisms of arterial and venous aging are considered. The pathogenesis of venous diseases affecting older adults, including varicose veins, chronic venous insufficiency, and deep vein thrombosis, is discussed, and the potential contribution of venous pathologies to the onset of vascular cognitive impairment and neurodegenerative diseases is emphasized. It is our hope that a greater appreciation of the cellular and molecular processes of vascular aging will stimulate further investigation into strategies aimed at preventing or retarding age-related venous pathologies.

                Author and article information

                Contributors
                Journal
                Eur Heart J
                Eur Heart J
                eurheartj
                European Heart Journal
                Oxford University Press (US )
                0195-668X
                1522-9645
                01 July 2023
                13 February 2023
                13 February 2023
                : 44
                : 25 , Focus Issue on Dyslipidaemias
                : 2349
                Affiliations
                Department of Cardiovascular Medicine, Kitasato University School of Medicine , 1-15-1, Kitazato, Minami, Sagamihara, Kanagawa 252-0375, Japan
                Department of Cardiovascular Medicine, Kitasato University Kitasato Institute Hospital , 5-9-1, Shirokane, Minato-ku, Tokyo 108-8642, Japan
                Department of Pathology, Kitasato University Kitasato Institute Hospital , 5-9-1, Shirokane, Minato-ku, Tokyo 108-8642, Japan
                Department of Pathology, Kitasato University School of Medicine , 1-15-1, Kitazato, Minami, Sagamihara, Kanagawa 252-0375, Japan
                Department of Cardiovascular Medicine, Kitasato University Kitasato Institute Hospital , 5-9-1, Shirokane, Minato-ku, Tokyo 108-8642, Japan
                Author notes
                Corresponding author. Email: ttojo@ 123456med.kitasato-u.ac.jp
                Author information
                https://orcid.org/0000-0002-9110-4440
                Article
                ehad072
                10.1093/eurheartj/ehad072
                10314321
                36779936
                adfb1424-9c78-4878-a84b-0cfb18d3970b
                © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                Page count
                Pages: 1
                Categories
                Cardiovascular Flashlight
                AcademicSubjects/MED00200
                Eurheartj/42
                Eurheartj/44
                Eurheartj/43
                Eurheartj/31
                Eurheartj/35
                Eurheartj/48
                Eurheartj/51

                Cardiovascular Medicine
                Cardiovascular Medicine

                Comments

                Comment on this article

                Related Documents Log